HUP9904129A2 - Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék - Google Patents

Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék

Info

Publication number
HUP9904129A2
HUP9904129A2 HU9904129A HUP9904129A HUP9904129A2 HU P9904129 A2 HUP9904129 A2 HU P9904129A2 HU 9904129 A HU9904129 A HU 9904129A HU P9904129 A HUP9904129 A HU P9904129A HU P9904129 A2 HUP9904129 A2 HU P9904129A2
Authority
HU
Hungary
Prior art keywords
sustained
diltiazem
active principle
layer
microgranules containing
Prior art date
Application number
HU9904129A
Other languages
English (en)
Inventor
Patrice Debregeas
Gérard LeDuc
Pascal Oury
Pascal Suplie
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9904129(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Des Produits Ethiques Ethypharm filed Critical Laboratoires Des Produits Ethiques Ethypharm
Publication of HUP9904129A2 publication Critical patent/HUP9904129A2/hu
Publication of HUP9904129A3 publication Critical patent/HUP9904129A3/hu
Publication of HU224214B1 publication Critical patent/HU224214B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya diltiazemet tartalmazó és vízőldható szerves savmentes, nyújtőtt hatóanyag-leadású (LP) mikrőszemcsék, amelyek akövetkezőket tartalmazzák: - egy semleges szemcsés hőrdőzóanyagőt,amely a következőkből álló aktív réteggel van bevőnva: - hatóanyagkéntdiltiazem vagy annak valamely gyógyszerészetileg alkalmazható sója, -felületaktív anyag, - kötőanyag, és - egy őlyan réteget, amelybiztősítja a hatóanyag nyújtőtt leadását (LP) réteg. A találmány amikrőszemcséket tartalmazó kapszűlákra is vőnatkőzik. ŕ
HU9904129A 1995-12-22 1996-12-23 Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék HU224214B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (3)

Publication Number Publication Date
HUP9904129A2 true HUP9904129A2 (hu) 2000-04-28
HUP9904129A3 HUP9904129A3 (en) 2000-11-28
HU224214B1 HU224214B1 (hu) 2005-06-28

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904129A HU224214B1 (hu) 1995-12-22 1996-12-23 Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék

Country Status (27)

Country Link
US (3) US6228395B1 (hu)
EP (1) EP0868184B1 (hu)
JP (1) JP2000506500A (hu)
KR (1) KR100354054B1 (hu)
CN (1) CN1145488C (hu)
AR (1) AR004410A1 (hu)
AT (1) ATE238798T1 (hu)
AU (1) AU721949B2 (hu)
BG (1) BG63770B1 (hu)
BR (1) BR9612225A (hu)
CA (1) CA2242224C (hu)
DE (1) DE69627880T2 (hu)
DK (1) DK0868184T3 (hu)
EA (1) EA001721B1 (hu)
EE (1) EE04045B1 (hu)
ES (1) ES2198505T3 (hu)
FR (1) FR2742660B1 (hu)
GE (1) GEP20022629B (hu)
HK (1) HK1018400A1 (hu)
HU (1) HU224214B1 (hu)
IL (1) IL125047A (hu)
NO (1) NO324680B1 (hu)
NZ (1) NZ324739A (hu)
PL (1) PL186621B1 (hu)
PT (1) PT868184E (hu)
WO (1) WO1997023219A1 (hu)
ZA (1) ZA9610776B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
MXPA06003942A (es) * 2003-10-10 2006-07-05 Ethypharm Sa Microgranulos de liberacion sostenida que contienen extracto de gingko biloba, y procedimiento para la fabricacion de los mismos.
JPWO2005065715A1 (ja) * 2003-12-25 2007-07-26 武田薬品工業株式会社 造粒性改善方法
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
CA2655835C (en) * 2006-06-19 2015-07-21 Alpharma, Inc. Abuse-resistant pharmaceutical compositions of opioid agonists
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
KR100354054B1 (ko) 2003-02-14
NO982738D0 (no) 1998-06-12
DE69627880T2 (de) 2004-03-11
CN1207681A (zh) 1999-02-10
DE69627880D1 (de) 2003-06-05
KR19990076717A (ko) 1999-10-15
FR2742660A1 (fr) 1997-06-27
WO1997023219A1 (fr) 1997-07-03
AU1198397A (en) 1997-07-17
BR9612225A (pt) 1999-07-13
AU721949B2 (en) 2000-07-20
GEP20022629B (en) 2002-02-25
JP2000506500A (ja) 2000-05-30
ATE238798T1 (de) 2003-05-15
IL125047A (en) 2003-05-29
IL125047A0 (en) 1999-01-26
EE04045B1 (et) 2003-06-16
NZ324739A (en) 2000-01-28
ZA9610776B (en) 1997-06-30
CA2242224C (fr) 2004-01-13
BG102555A (en) 1999-02-26
CA2242224A1 (fr) 1997-07-03
EA001721B1 (ru) 2001-08-27
ES2198505T3 (es) 2004-02-01
HUP9904129A3 (en) 2000-11-28
DK0868184T3 (da) 2003-08-25
US6383516B1 (en) 2002-05-07
NO324680B1 (no) 2007-12-03
PL327567A1 (en) 1998-12-21
US6228395B1 (en) 2001-05-08
EE9800197A (et) 1998-12-15
FR2742660B1 (fr) 1998-04-03
BG63770B1 (bg) 2002-12-29
AR004410A1 (es) 1998-11-04
NO982738L (no) 1998-08-21
US6660296B2 (en) 2003-12-09
EP0868184B1 (fr) 2003-05-02
PT868184E (pt) 2003-09-30
HU224214B1 (hu) 2005-06-28
CN1145488C (zh) 2004-04-14
EP0868184A1 (fr) 1998-10-07
EA199800593A1 (ru) 1998-12-24
PL186621B1 (pl) 2004-02-27
US20020182253A1 (en) 2002-12-05
HK1018400A1 (en) 1999-12-24

Similar Documents

Publication Publication Date Title
HUP9904129A2 (hu) Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék
HUP0002935A2 (hu) Gyomorban visszatartott, szabályozott hatóanyag kibocsátású mikrogömböcskék javított gyógyszeradagolás elősegítésére
KR930003905A (ko) 약학적 결합 제제
PT1007009E (pt) Composicao farmaceutica que possui duas camadas de revestimento
PT1003484E (pt) Comprimido de multi-particulas aperfeicoado com rapida desintegracao
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
KR890009380A (ko) 서방성 약학제제
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
HUP0002797A2 (hu) Késleltetett hatású gyógyszeradagoló rendszerek
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
NO20016108L (no) Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger
CA2145513A1 (en) Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
NL192819B (nl) Met een hydroxypropylmethylcellulosefilm beklede tablet van ranitidine hydrochloride.
CY1107909T1 (el) Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη
HUP9904065A2 (hu) Olanzapint tartalmazó bevonatos gyógyszerkészítmények
DE59904737D1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
KR950031052A (ko) 알푸조신 히드로클로라이드의 서방성 투약형태
ATE66371T1 (de) Arzneimittelzubereitung mit verzoegerter freisetzung.
DE60018629D1 (de) Carbamazepinformulierung mit verzögerter Freigabe
NO985299D0 (no) Preparat av prostaglandin I-derivat med langsom frigj°ring
NO308693B1 (no) Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider for fremstilling av medikamenter for forebyggelse av emesis
NO975567D0 (no) Preparat med kontrollert frigivelse av aktiv substans
HUP9902458A2 (hu) Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050503